Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Launay

Showing results (1-10 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Rheumatology|September 3, 2016
A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?David Launay
Presse Medicale (Paris, France : 1983)|December 24, 2014
[Angioedema: differential diagnosis]David Launay
La Revue Du Praticien|January 21, 2003
[Cardiac and pulmonary involvement in scleroderma]David Launay, Eric Hachulla
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Inflammatory aortitis]David Launay, Eric Hachulla
Clinical Reviews in Allergy & Immunology|February 10, 2010
Diagnosis and classification of systemic sclerosisEric Hachulla, David Launay
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Pulmonary arterial hypertension and systemic sclerosis]David Launay, Marc Humbert, Eric Hachulla
The European Respiratory Journal|June 25, 2021
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertensionDavid Launay, Sébastien Sanges, Vincent Sobanski
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
Presse Medicale (Paris, France : 1983)|November 24, 2007
[Iloprost for the treatment of systemic sclerosis]Eric Hachulla, David Launay, Pierre-Yves Hatron
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
Pageof 31

Showing results (1-10 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|September 3, 2016
A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?David Launay
Presse Medicale (Paris, France : 1983)|December 24, 2014
[Angioedema: differential diagnosis]David Launay
La Revue Du Praticien|January 21, 2003
[Cardiac and pulmonary involvement in scleroderma]David Launay, Eric Hachulla
Presse Medicale (Paris, France : 1983)|December 24, 2004
[Inflammatory aortitis]David Launay, Eric Hachulla
Clinical Reviews in Allergy & Immunology|February 10, 2010
Diagnosis and classification of systemic sclerosisEric Hachulla, David Launay
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Pulmonary arterial hypertension and systemic sclerosis]David Launay, Marc Humbert, Eric Hachulla
The European Respiratory Journal|June 25, 2021
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertensionDavid Launay, Sébastien Sanges, Vincent Sobanski
Current Opinion in Rheumatology|September 17, 2020
Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doorsVincent Sobanski, Alain Lescoat, David Launay
Presse Medicale (Paris, France : 1983)|November 24, 2007
[Iloprost for the treatment of systemic sclerosis]Eric Hachulla, David Launay, Pierre-Yves Hatron
Current Rheumatology Reports|February 5, 2016
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Vincent Sobanski, David Launay, Eric Hachulla, et al.
Pageof 31